International Expansion Accelerates Hims & Hers 38% Revenue Surge

Ethan Wright 08/12/2026

Hims & Hers Health is not just growing; it’s expanding at warp speed, demonstrating that the appetite for accessible health and wellness solutions is bigger than ever. The company recently reported impressive results for the second quarter of 2026, showcasing robust growth fueled by aggressive international expansion and a rapidly maturing subscriber base.

The numbers paint a vivid picture of momentum. Revenue soared to US$753.2 million year-on-year, marking a remarkable 38% growth. This acceleration was supported by a healthy increase in subscribers, which jumped by 19% to nearly 2.9 million users.

Where this growth is most exciting is in the global footprint. While U.S. revenue climbed by 16% to US$621.8 million, international sales experienced a massive surge, hitting US$131.4 million. This global expansion was significantly bolstered by strategic moves, including the successful acquisition of Eucalyptus in June.

The operational efficiency also saw improvements; monthly revenue per average subscriber increased by 21%, reaching an impressive US$92. These figures highlight that Hims & Hers is not just adding volume but is successfully optimizing its service delivery and pricing strategy across different markets.

However, the pursuit of rapid growth comes with its own financial reality. Despite the stellar top-line performance, the company recorded a net loss of US$86.3 million for the quarter, compared to a net income of US$42.5 million a year prior. This dip in profitability reflects the significant investment required to fuel this ambitious international scaling and platform development.

The story behind the growth is rooted in Hims & Hers’ commitment to transforming the consumer health and wellness landscape. The company is successfully positioning itself as an integrated, doctor-led healthcare platform, leveraging artificial intelligence to deliver personalized solutions that are both effective and highly accessible.

Looking ahead, the company is confident in its trajectory. Hims & Hers has raised its full-year sales outlook, anticipating revenue between US$3.1 billion and US$3.3 billion for 2026. Furthermore, management expects Q3 revenue to settle between US$880 million and US$900 million, signaling continued strong momentum as the platform matures and expands its reach.

Ultimately, Hims & Hers’ results tell a compelling story of scaling innovation. They are successfully navigating the complexities of international growth while making strategic investments in technology, positioning themselves firmly at the intersection of consumer demand and advanced healthcare delivery.